/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

R

Richard Nathan

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

21

Papers

2.2K

Citations

11

h-index

13

i10-index

Richard Nathan is an academic researcher. The author has contributed to research in topics: Clostridium difficile and Clostridium perfringens research & Microscopic Colitis & Gut microbiota and health. The author has an h-index of 11, co-authored 18 publications.

Research Topics

Clostridium difficile and Clostridium perfringens research Microscopic Colitis Gut microbiota and health Gastrointestinal motility and disorders Viral gastroenteritis research and epidemiology

Papers by this author

works

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

2017 · The Lancet Infectious Diseases · 115 citations

https://doi.org/10.1016/s1473-3099(17)30235-9

Richard Vickers Glenn Tillotson Richard Nathan Sabine Hazan

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

2017 · The Lancet Infectious Diseases · 115 citations

https://doi.org/10.1016/s1473-3099(17)30235-9

Richard Vickers Glenn Tillotson Richard Nathan Sabine Hazan

Research topics

topics

Clostridium difficile and Clostridium perfringens research

Microscopic Colitis

Gut microbiota and health

Gastrointestinal motility and disorders

Viral gastroenteritis research and epidemiology

Chat about Author

Papers

Chat

Click to start Chat